Background/Aims: The present study was a retrospective analysis of surgical outcomes of large or giant vestibular schwannomas (VSs) via a translabyrinthine approach (TLA). Methods: One hundred and fifteen sporadic large or giant VSs (maximal diameter in the cerebellopontine angle ≥31 mm) were operated via TLA between January 2001 and December 2010. We divided patients into two groups: cystic VS (CVS) and solid VS (SVS) group. The surgical outcomes were recorded and compared. Results: Total, near total, and subtotal tumor removal rate was 89.6, 7.8, and 2.6%, respectively. The near total removal rate in CVS was higher than that in SVS (16.7 vs. 3.8%). The anatomical facial nerve (FN) integrity was preserved in 101 patients (87.8%). More FNs in CVS were interrupted (22.2%). There were 29.6, 56.5, and 13.9% of patients who had a short-term (1 month) FN function of House-Brackmann grade I or II, III or IV, and V or VI, respectively. The CVS had worse FN function than the SVS group. The mortality rate was 0.9%. Cerebrospinal fluid leakage occurred in 8 patients (7.0%). Four (3.5%) patients had recurrence. Conclusions: Cyst formation is a crucial factor for surgical outcome of VS. With near total or subtotal tumor removal, worse functional outcomes in large or giant CVSs should be foreseen.

Keywords:
Vestibular schwannoma, Large vestibular schwannoma, Cystic vestibular schwannoma, Facial nerve function, Complication
1.
Anderson DE, Leonetti J, Wind JJ, Cribari D, Fahey K: Resection of large vestibular schwannomas: facial nerve preservation in the context of surgical approach and patient-assessed outcome. J Neurosurg 2005;102:643–649.
2.
Samii M, Gerganov VM, Samii: A Functional outcome after complete surgical removal of giant vestibular schwannomas. J Neurosurg 2010;112:860–867.
3.
Yamakami I, Uchino Y, Kobayashi E, Yamaura A, Oka N: Removal of large acoustic neurinomas (vestibular schwannomas) by the retrosigmoid approach with no mortality and minimal morbidity. J Neurol Neurosurg Psychiatry 2004;75:453–458.
4.
Kanzaki J, Tos M, Sanna M, Moffat DA, Monsell EM, Berliner KI: New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol 2003;24:642–648; discussion 648–649.
5.
Angeli RD, Piccirillo E, Di Trapani G, Sequino G, Taibah A, Sanna M: Enlarged translabyrinthine approach with transapical extension in the management of giant vestibular schwannomas: personal experience and review of literature. Otol Neurotol 2011;32:125–131.
6.
Godefroy WP, van der Mey AG, de Bruine FT, Hoekstra ER, Malessy MJ: Surgery for large vestibular schwannoma: residual tumor and outcome. Otol Neurotol 2009;30:629–634.
7.
Mamikoglu B, Wiet RJ, Esquivel CR: Translabyrinthine approach for the management of large and giant vestibular schwannomas. Otol Neurotol 2002;23:224–227.
8.
Roland JT Jr, Fishman AJ, Golfinos JG, Cohen N, Alexiades G, Jackman AH: Cranial nerve preservation in surgery for large acoustic neuromas. Skull Base 2004;14:85–90; discussion 90–91.
9.
Charpiot A, Tringali S, Zaouche S, Ferber-Viart C, Dubreuil C: Perioperative complications after translabyrinthine removal of large or giant vestibular schwannoma: outcomes for 123 patients. Acta Otolaryngol 2010;130:1249–1255.
10.
Jones SE, Baguley DM, Moffat DA: Are facial nerve outcomes worse following surgery for cystic vestibular schwannoma? Skull Base 2007;17:281–284.
11.
Moon KS, Jung S, Seo SK, Jung TY, Kim IY, Ryu HH, Jin YH, Jin SG, Jeong YI, Kim KK, Kang SS: Cystic vestibular schwannomas: a possible role of matrix metalloproteinase-2 in cyst development and unfavorable surgical outcome. J Neurosurg 2007;106:866–871.
12.
Piccirillo E, Wiet MR, Flanagan S, Dispenza F, Giannuzzi A, Mancini F, Sanna M: Cystic vestibular schwannoma: classification, management, and facial nerve outcomes. Otol Neurotol 2009;30:826–834.
13.
Sinha S, Sharma BS: Cystic acoustic neuromas: surgical outcome in a series of 58 patients. J Clin Neurosci 2008;15:511–515.
14.
Falcioni A, Piccirillo E, Mancini F: Cystic vestibular schwannoma. Am J Otol 2000;21:595–596.
15.
Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC. Otolaryngol Head Neck Surg 1995;113:179–180.
16.
House WF, Hitselberger WE: Transtemporal bone microsurgical removal of acoustic neuromas. Morbidity and mortality of acoustic neuromas. Arch Otolaryngol 1964;80:752–754.
17.
Wu H, Sterkers J: Translabyrinthine removal of large acoustic neuromas in young adults. Auris Nasus Larynx 2000;27:201–205.
18.
Stangerup SE, Tos M, Thomsen J, Caye-Thomasen P: True incidence of vestibular schwannoma? Neurosurgery 2010;67:1335–1340; discussion 1340.
19.
Mehrotra N, Behari S, Pal L, Banerji D, Sahu RN, Jain VK: Giant vestibular schwannomas: focusing on the differences between the solid and the cystic variants. Br J Neurosurg 2008;22:550–556.
20.
Tos M, Stangerup SE, Cayé-Thomasen P, Tos T, Thomsen J: What is the real incidence of vestibular schwannoma? Arch Otolaryngol Head Neck Surg 2004;130:216–220.
21.
Bozorg Grayeli A, Kalamarides M, Ferrary E, Bouccara D, El Gharem H, Rey A, Sterkers O: Conservative management versus surgery for small vestibular schwannomas. Acta Otolaryngol 2005;125:1063–1068.
22.
Welling DB: Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas). Laryngoscope 1998;108:178–189.
23.
Yokoh A, Kobayashi S, Tanaka Y, Gibo H, Sugita K: Preservation of cochlear nerve function in acoustic neurinoma surgery. Acta Neurochir (Wien) 1993;123:8–13.
24.
Kameyama S, Tanaka R, Kawaguchi T, Fukuda M, Oyanagi K: Cystic acoustic neurinomas: studies of 14 cases. Acta Neurochir (Wien) 1996;138:695–699.
25.
Gomez-Brouchet A, Delisle MB, Cognard C, Bonafe A, Charlet JP, Deguine O, Fraysse B: Vestibular schwannomas: correlations between magnetic resonance imaging and histopathologic appearance. Otol Neurotol 2001;22:79–86.
26.
Muzumdar DP, Goel A, Pakhmode CK: Multicystic acoustic neurinoma: report of two cases. J Clin Neurosci 2002;9:453–455.
27.
Park CK, Kim DC, Park SH, Kim JE, Paek SH, Kim DG, Jung HW: Microhemorrhage, a possible mechanism for cyst formation in vestibular schwannomas. J Neurosurg 2006;105:576–580.
28.
Sanna M, Russo A, Taibah A, Falcioni M, Agarwal M: Enlarged translabyrinthine approach for the management of large and giant acoustic neuromas: a report of 175 consecutive cases. Ann Otol Rhinol Laryngol 2004;113:319–328.
29.
Zaouche S, Ionescu E, Dubreuil C, Ferber-Viart C: Pre- and intraoperative predictive factors of facial palsy in vestibular schwannoma surgery. Acta Otolaryngol 2005;125:363–369.
30.
Charabi S, Tos M, Børgesen SE, Thomsen J: Cystic acoustic neuromas. Results of translabyrinthine surgery. Arch Otolaryngol Head Neck Surg 1994;120:1333–1338.
31.
Fundová P, Charabi S, Tos M, Thomsen J: Cystic vestibular schwannoma: surgical outcome. J Laryngol Otol 2000;114:935–939.
32.
Merkus P, Taibah A, Sequino G, Sanna M: Less than 1% cerebrospinal fluid leakage in 1,803 translabyrinthine vestibular schwannoma surgery cases. Otol Neurotol 2010;31:276–283.
33.
House JL, Hitselberger WE, House WF: Wound closure and cerebrospinal fluid leak after translabyrinthine surgery. Am J Otol 1982;4:126–128.
34.
Couldwell WT, Fukushima T: Cosmetic mastoidectomy for the combined supra/infratentorial transtemporal approach. Technical note. J Neurosurg 1993;79:460–461.
35.
Bambakidis NC, Munyon C, Ko A, Selman WR, Megerian CA: A novel method of translabyrinthine cranioplasty using hydroxyapatite cement and titanium mesh: a technical report. Skull Base 2010;20:157–161.
36.
Goddard JC, Oliver ER, Lambert PR: Prevention of cerebrospinal fluid leak after translabyrinthine resection of vestibular schwannoma. Otol Neurotol 2010;31:473–477.
37.
Jacob A, Bortman JS, Robinson LL Jr, Yu L, Dodson EE, Welling DB: Does packing the Eustachian tube impact cerebrospinal fluid rhinorrhea rates in translabyrinthine vestibular schwannoma resections? Otol Neurotol 2007;28:934–938.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.